Hyperphosphatemia
📧 Sign up to get email alerts when something new happens for Hyperphosphatemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-06-29FDA Approved: CALCIUM ACETATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a generic calcium acetate under an Original Application (ANDA 202315) from Heritage Pharmaceuticals (d/b/a Avet) to treat h…
-
FDA approval · 2015-06-09FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for sevelamer hydrochloride (Renagel) submitted by Sanofi-Aventis U.S. LLC. The approval updates the…
-
FDA approval · 2015-05-22FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Ferric Citrate from Mylan Pharmaceuticals, expanding the regulatory approval for the product.
-
FDA approval · 2015-05-18FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application from Mylan Pharmaceuticals Inc. for Ferric Citrate, approving a generic version of the iron-based ph…
-
FDA approval · 2014-11-26FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Sevelamer Hydrochloride by Sanofi-Aventis U.S. LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-11-26FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Sevelamer carbonate (Renvela), a phosphate binder used to control hyperphosphatemia in chronic k…
-
FDA approval · 2014-11-26FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Renvela (sevelamer carbonate) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2014-11-15FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Ferric Citrate by Mylan Pharmaceuticals Inc.
-
FDA approval · 2014-10-06FDA Approved: CALCIUM ACETATE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approves Amneal Pharmaceuticals of New York LLC's calcium acetate under an Original Application (ANDA) as a generic phosphate binder to …
-
FDA approval · 2014-09-24FDA Approved: FOSRENOL — Original Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved Fosrenol (lanthanum carbonate) through Takeda's original NDA to treat hyperphosphatemia in adults with chronic kidney disea…
-
FDA approval · 2014-09-24FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2014-09-24FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)
The FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) from Fresenius Medical Care Renal Therapies Group, LLC.
-
FDA approval · 2014-09-05FDA Approved: FERRIC CITRATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Ferric Citrate from Mylan as an original application to treat hyperphosphatemia in adults with chronic kidney disease on dialys…
-
FDA approval · 2013-11-27FDA Approved: VELPHORO — Original Application (Fresenius Medical Care Renal Therapies Group, LLC)
FDA approved Velphoro (sucroferric oxyhydroxide) under an original NDA for the treatment of hyperphosphatemia in adults with chronic kidney …
-
FDA approval · 2013-02-07FDA Approved: CALCIUM ACETATE — Original Application (Cipla USA Inc.,)
The FDA approved Cipla USA Inc.'s original application for Calcium Acetate (generic calcium acetate).
-
FDA approval · 2013-02-05FDA Approved: CALCIUM ACETATE — Original Application (Chartwell RX LLC)
FDA approves Chartwell RX LLC's calcium acetate as a new generic phosphate binder under an Original Application (ANDA 202420).
-
FDA approval · 2012-10-31FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Fosrenol (lanthanum carbonate) filed by Takeda Pharmaceuticals America, expanding the product's …
-
FDA approval · 2012-06-01FDA Approved: CALCIUM ACETATE — Original Application (Chartwell RX, LLC.)
FDA approved the original application for calcium acetate (Calcium Acetate) by Chartwell RX, LLC as a generic drug.
-
FDA approval · 2011-09-02FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Fosrenol (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2011-06-16FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for sevelamer hydrochloride (Sanofi-Aventis U.S. LLC).
-
FDA approval · 2011-06-16FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for sevelamer carbonate (Renvela) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2009-08-12FDA Approved: SEVELAMER CARBONATE — Original Application (Sanofi-Aventis U.S. LLC)
FDA approved Sevelamer carbonate (brand Renvela) via an original NDA to treat hyperphosphatemia in adults with chronic kidney disease on dia…
-
FDA approval · 2008-10-23FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2008-10-02FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2008-04-10FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) from Takeda Pharmaceuticals America, resulting in an approved lab…